🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

344 results for “AVI” Clear

  1. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    approved other completed

    2 trials

  2. Behavioral Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved other completed

    1 trial

  3. Behavioral: Buprenorphine/naloxone maintenance (Mtn)

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    approved other completed

    1 trial

  4. Entecavir + Placebo

    ShuGuang Hospital

    Liver Cirrhosis Due to Hepatitis B Virus

    approved small molecule active

    1 trial

  5. Entecavir+Fuzheng Huayu+TCM Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Virus Related Cirrhosis

    approved small molecule active

    1 trial

  6. Entecavir, Adefovir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  7. Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

  8. Fluad Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted), Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Vaxigrip injektioneste, suspensio, esitäytetty ruisku. Kolmivalenttinen influenssarokote (virusfragmentit, inaktivoitu)., Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuva

    The George Institute

    Avian influenza and seasonal influenza

    approved small molecule active

    1 trial

  9. Fluocinolone Acetonide Intravitreal Implant 0.18 mg

    ANI PHARMACEUTICALS INC

    Uveitis, Posterior

    approved small molecule active

    1 trial

  10. Fluoxetine + outpatient cognitive behavioral therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    approved small molecule completed

    1 trial

  11. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  12. Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pierre Fabre Australia Pty Ltd

    giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral

    approved small molecule active

    1 trial

  13. Intravitreal Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule terminated

    2 trials

  14. Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Cystoid Macular Edema

    approved small molecule completed

    1 trial

  15. Intravitreal Aflibercept Injection (IAI)

    Regeneron UK Limited

    Chorioretinal Vascular Disease

    approved small molecule completed

    1 trial

  16. Intravitreal Aflibercept Injection (IAI)

    Regeneron UK Limited

    Age - Related Macular Degeneration (AMD)

    approved small molecule completed

    1 trial

  17. Intravitreal Aflibercept Injection 2mg

    Regeneron UK Limited

    Neovascular Age-related Macular Degeneration

    approved small molecule active

    2 trials

  18. Intravitreal aflibercept injection

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

  19. Intravitreal aflibercept injection 2.0mg

    Regeneron UK Limited

    Polypoidal Choroidal Vasculopathy

    approved small molecule completed

    1 trial

  20. Jakavi 5 mg tablets, Jakavi 10 mg tablets, Jakavi 15 mg tablets, Jakavi 20 mg tablets, Jakavi 5 mg tablets, HDM201, RUXOLITINIB, Jakavi 20 mg tablets, Farydak 15 mg hard capsules, Jakavi 10 mg tablets, Jakavi 15 mg tablets, Jakavi 5 mg tablets, Farydak 10 mg hard capsules, Jakavi 10 mg tablets, Jakavi 15 mg tablets, HDM201, Jakavi 20 mg tablets

    Novartis Pharmaceuticals

    This study is designed to accept patients with varied disease origins, depending on the parent protocol

    approved small molecule active

    1 trial

  21. Maribavir

    Takeda

    Transplant Complication

    approved small molecule completed

    1 trial

  22. Metformin Actavis 500 mg filmdragerad tablett

    The George Institute

    Polycystic ovary syndrome

    approved small molecule active

    1 trial

  23. Nelfinavir and Omeprazole

    Jasper Therapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial

  24. Nifedipine 30 MG

    Yang I. Pachankis

    Severe Acute Respiratory Syndrome-related Coronavirus

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources